May 14 – 15, 2018

 Bridge to Pop Health in Boston provides the platform for collaborative discussion on maximizing outcomes through predictive models, population health management and clinical care innovation. Now in its sixth year, the event has become the annual meeting place for thought leaders from the provider, payer and technology communities. 

Here is a sample list of speakers for the conference:

  • Sachin Jain, MD, MBA CMO, CareMore Health System/Anthem
  • Steven Atlas, MD, MPH Director, Practice-Based Research & Quality Improvement, Massachusetts General Hospital
  • Katy Mahraj Director of Innovation, Women’s Health, Penn Medicine
  • Harry Saag, MD Medical Director, Network Integration, NYU Langone Health
  • Joe Kimura, MD, MPH CMO, Atrius Health Randall Moore, MD, MBA President, Mercy Virtual
  • Gowtham Rao, MD, PhD CMIO, BlueCross BlueShield of South Carolina
  • Scott Sarran, MD CMO, Government Programs, Clinical Strategy, Health Care Service Corp.
  • Janet O’Hollaren COO, Northwest, Kaiser Foundation Health Plan and Hospitals
  • Mahek Shah, MD Value Measurement for Healthcare Delivery, Harvard Business School

For information on the conference and to register, click here.

June 4 – 7, 2018

I am pleased to announce that I will be moderating a panel discussion entitled “Our Microbiome and Its Relationship to Various Diseases” under the Next Generation Biotherapeutics Track.  This session is scheduled for Monday, June 4th 2018 from 1:00 PM – 2:15 PM.  The location is Room 210B, Level 2 at the Boston Convention Center.  The session will focus on the application and implication of our microbiome specifically looking at microbiome signatures (dominance and absence of certain species) for different diseases and it’s implication in restoring symbiosis.

Please join me for a very informative and interactive panel discussion with some of the top researchers and companies working in this space.  My distinguish panel of speakers:

1.     JC Gutierrez-Ramos, CEO, Synlogic Therapeutics

2.     Matt Henn, Executive Vice President, Microbiome Research and Development, Seres Therapeutics

3.     Philip Strandwitz, Co-founder and CEO, Holobiome

4.     Sonia Timberlake, VP Research, Finch Therapeutic

For more information on BIO and to register, click here